After 400% Surge, Should Investors Care About Monte Rosa Insider Sale?
A biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
Learn about effective wealth building actions for this year that can enhance your savings and investment strategies for long-term success.
24,006 articlesA biotech stock sprinted 400% in a year, and an insider sale worth about $882k followed. The question for investors: ...
AI investing often spotlights flashy chips, but the real winners are the enablers. Rambus sits at the nexus of securi...
Lawmakers pivot from buyer subsidies to boosting the nation’s housing stock. The road housing bill’s biggest breakthr...
A veteran portfolio manager says the real crowded trade is hiding in plain sight, far from the Mag 7 narrative. He po...
A new AI-driven forecast highlights two XRP price paths tied to a key CLARITY Act vote, with a possible surge to $5 o...
Investors ask whether to buy Domino's stock before a major investor update. This guide breaks down the decision, back...
Remote work holds steady around 22% of US workers in early 2026, defying headlines of a mass office return. New data ...
Only a small slice of workers over 50 tap catch-up contributions in 2026, even with higher limits. Inflation, housing...
Prediction markets are painting a different picture from AI headlines, placing Anthropic ahead of OpenAI for a 2026 l...
A ChatGPT-based forecast tied to Sam Altman envisions Bitcoin rising to $125K by end-2026, with a potential surge to ...
XRP slid below $1.10 while XRP ETFs showed back-to-back days with no net inflows, sparking questions about whether bi...
MediaTek launches its most powerful custom AI accelerator to date, tying a 25% discount to early commitments and sign...